scholarly article | Q13442814 |
P50 | author | Ênio José Bassi | Q55190795 |
Niels Camara | Q42624713 | ||
Thomas Thornley | Q42767201 | ||
P2093 | author name string | Pedro Manoel Moraes-Vieira | |
Alvaro Pacheco-Silva | |||
Danilo Candido de Almeida | |||
Patrícia Semedo | |||
Marina Burgos da Silva | |||
Rafael Assumpção Larocca | |||
P2860 | cites work | Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 |
Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
Human adipose tissue is a source of multipotent stem cells | Q29617385 | ||
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 | ||
Human mesenchymal stem cells modulate B-cell functions | Q29620705 | ||
Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells | Q30436128 | ||
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway. | Q31101562 | ||
Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. | Q33853487 | ||
Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. | Q34007524 | ||
Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells | Q34333949 | ||
Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction | Q34339063 | ||
IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease | Q34491107 | ||
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease | Q34556560 | ||
Adipose-derived stem cells: isolation, expansion and differentiation | Q34790957 | ||
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis | Q34928194 | ||
Regulatory T cells in transplantation tolerance | Q35092535 | ||
Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. | Q50998508 | ||
Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens | Q52005550 | ||
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. | Q54671130 | ||
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide | Q61645540 | ||
Mesenchymal Stem Cells Require a Sufficient, Ongoing Immune Response to Exert Their Immunosuppressive Function | Q61878551 | ||
Organ transplantation (skin, kidney, heart) and the plastic surgeon | Q69934139 | ||
Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection | Q74388385 | ||
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex | Q78833880 | ||
[Effect of Interleukin-17 on neutrophil apoptosis] | Q79736568 | ||
[The role of neutrophils during allograft rejection] | Q80076417 | ||
IFATS collection: Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model | Q82193331 | ||
Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells | Q84331120 | ||
Role of IFN-gamma in allograft rejection | Q35100146 | ||
Prevention of neutrophil migration ameliorates rat lung allograft rejection | Q35586910 | ||
The many faces of Th17 cells | Q35596984 | ||
Immunomodulatory effects of fetal and adult mesenchymal stem cells | Q35601901 | ||
An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation | Q35844999 | ||
CD4 memory T cells survive and proliferate but fail to differentiate in the absence of CD40 | Q36228513 | ||
Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. | Q36249780 | ||
Long-term problems related to immunosuppression. | Q36677964 | ||
Mesenchymal stromal cells in transplantation rejection and tolerance | Q36786630 | ||
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects | Q36826059 | ||
The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells | Q37236517 | ||
Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. | Q37382702 | ||
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes | Q37492370 | ||
Immune responses in transplantation: application to composite tissue allograft | Q37766767 | ||
Regulatory immune cells in transplantation | Q38013048 | ||
Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? | Q38064659 | ||
Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. | Q39698715 | ||
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells | Q40229749 | ||
Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanisms | Q40373804 | ||
Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism | Q42828277 | ||
Maximal inflammatory response benefits syngeneic skin graft acceptance | Q43703316 | ||
Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis | Q43831215 | ||
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation | Q44317237 | ||
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation | Q44786842 | ||
Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. | Q45834735 | ||
Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality | Q45856815 | ||
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness | Q45879145 | ||
Adipose-derived stem cell: a better stem cell than BMSC. | Q46276954 | ||
Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. | Q46670167 | ||
Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche | Q46954203 | ||
Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells | Q47372947 | ||
Human adipose stem cells: a potential cell source for cardiovascular tissue engineering | Q47975892 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mesenchymal stem cell | Q1922379 |
P304 | page(s) | e76396 | |
P577 | publication date | 2013-10-04 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Adipose tissue-derived mesenchymal stem cells increase skin allograft survival and inhibit Th-17 immune response | |
P478 | volume | 8 |
Q37637831 | Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function |
Q91762342 | Cell Bioprinting: The 3D-Bioplotter™ Case |
Q26822005 | Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells |
Q35562203 | Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells |
Q35102019 | Fat and epidermal cell suspension grafting: a new advanced one-step skin regeneration surgical technique |
Q42512572 | Gelatin-chondroitin-6-sulfate-hyaluronic acid scaffold seeded with vascular endothelial growth factor 165 modified hair follicle stem cells as a three-dimensional skin substitute |
Q47122472 | Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin |
Q28067456 | Immunomodulatory Role of Mesenchymal Stem Cell Therapy in Vascularized Composite Allotransplantation |
Q39174364 | Impaired structural and functional regeneration of skeletal muscles from β2-adrenoceptor knockout mice. |
Q38727840 | Increased Paracrine Immunomodulatory Potential of Mesenchymal Stromal Cells in Three-Dimensional Culture |
Q27011792 | New advances in the mesenchymal stem cells therapy against skin flaps necrosis |
Q91558752 | Novel Therapeutic Approach Using Drug-loaded Adipose-derived Stem Cells for Pancreatic Cancer |
Q55401793 | Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models. |
Q90573411 | The suppression effect of dendritic cells maturation by adipose-derived stem cells through TGF-β1 related pathway |
Q37359699 | Use of Adipose-Derived Stem Cells to Support Topical Skin Adhesive for Wound Closure: A Preliminary Report from Animal In Vivo Study |
Search more.